1. Home
  2. GVH vs EVGN Comparison

GVH vs EVGN Comparison

Compare GVH & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

HOLD

Current Price

$6.00

Market Cap

11.5M

Sector

N/A

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.77

Market Cap

9.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GVH
EVGN
Founded
2016
1999
Country
Australia
Israel
Employees
N/A
N/A
Industry
Agricultural Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
9.6M
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
GVH
EVGN
Price
$6.00
$0.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$80.00
$3.50
AVG Volume (30 Days)
150.7K
44.0K
Earning Date
02-17-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$102,768.97
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
$0.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.72
52 Week High
$10.74
$2.42

Technical Indicators

Market Signals
Indicator
GVH
EVGN
Relative Strength Index (RSI) 85.92 44.84
Support Level $4.02 $0.73
Resistance Level N/A $0.87
Average True Range (ATR) 0.65 0.06
MACD 0.23 -0.00
Stochastic Oscillator 89.05 28.07

Price Performance

Historical Comparison
GVH
EVGN

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: